Artificial intelligence software designed to tackle missed appointments and reduce waiting lists will see its use by the NHS ramp up after a successful pilot deployment.
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use
Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says a new independent review conducted in the UK.
The UK government plans to link the NHS App to data generated by smart devices, including step counts and heart rate, for example, according to Health Secretary Victoria A
NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the U
GSK’s PD-1 inhibitor Jemperli has been cleared for use by the NHS as a first-line treatment for a specific type of endometrial cancer, making it an option for around 580 w
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment